- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on microRNAs in Attention-deficit/Hyperactivity Disorder
Total 1332 results
-
Hadassah Medical OrganizationCompletedAttention Deficit Hyperactivity DisorderIsrael
-
Wake Forest University Health SciencesCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Mensia Technologies SAEuropean Union H2020 SME InstrumentUnknownAttention Deficit-Hyperactivity DisorderFrance, Belgium, Germany, Spain, Switzerland
-
Indiana UniversityNational Library of Medicine (NLM)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Canada, Puerto Rico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderKorea, Republic of, Taiwan, Japan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderAustralia, United Kingdom, Mexico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Hartford HospitalYale UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderGermany
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderItaly, Spain, France, Belgium, Turkey, Ireland, Mexico, Norway, United Kingdom
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderTaiwan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom
-
Norwegian University of Science and TechnologyCompletedAttention Deficit Hyperactivity DisorderNorway
-
University Hospital, ToulouseCompleted
-
NYU Langone HealthCompletedAttention Deficit-HyperactivityUnited States
-
University Hospital, GrenobleUnknownAttention Deficit-HyperactivityFrance
-
Uppsala UniversitySwedish Council for Working Life and Social ResearchRecruitingAttention Deficit Hyperactivity DisorderSweden
-
Karolinska InstitutetCompletedAttention Deficit Hyperactivity DisorderSweden
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Rhodes Pharmaceuticals, L.P.CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
National Taiwan University HospitalNational Health Research Institutes, TaiwanCompletedAttention Deficit Hyperactivity DisorderTaiwan
-
Dokuz Eylul UniversityCompletedAttention Deficit Hyperactivity DisorderTurkey
-
State University of New York at BuffaloEli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Universidade Federal de PernambucoCompletedAttention Deficit/Hyperactivity Disorder
-
IRCCS Eugenio MedeaDMF srl (Dietetic Metabolic Food)CompletedAttention Deficit Hyperactivity DisorderItaly
-
Eli Lilly and CompanyTerminatedAttention Deficit Hyperactivity DisorderUnited States, Canada, Taiwan, Puerto Rico
-
Tris Pharma, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Tufts Medical CenterCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Noven TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Chang Gung Memorial HospitalUnknownAttention Deficit Hyperactivity DisorderTaiwan
-
Targacept Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
National Taiwan University HospitalCompletedAttention Deficit Hyperactivity DisorderTaiwan
-
Central Institute of Mental Health, MannheimHeidelberg UniversityCompletedAttention Deficit Hyperactivity DisorderGermany
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderChina, Taiwan, Korea, Republic of
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderKorea, Republic of, China, Taiwan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderChina, Mexico, Korea, Republic of
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderGermany
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderGermany
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderCanada
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderSweden
-
University of California, San DiegoNational Institute of Mental Health (NIMH); San Diego State University; University...RecruitingImplementation Science | Attention Deficit/ Hyperactivity Disorder | Team-effectiveness Research | School-based InterventionsUnited States
-
National Taiwan University HospitalRecruitingAutism Spectrum Disorder | Attention-Deficit Hyperactivity Disorder, Unspecified TypeTaiwan
-
University Health Network, TorontoShireCompletedBipolar Disorder | Attention Deficit/Hyperactivity DisorderCanada
-
Bradley HospitalNational Institute of Mental Health (NIMH)UnknownHealthy | Generalized Anxiety Disorder | Bipolar Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityUnited States
-
National Taiwan University HospitalCompletedAttention Deficit/Hyperactivity DisorderTaiwan